Cargando…

Hydroxynorketamine: Implications for the NMDA Receptor Hypothesis of Ketamine’s Antidepressant Action

The prevailing hypothesis of ketamine’s unique antidepressant effects implicates N-methyl-d-aspartate receptor (NMDAR) inhibition-dependent enhancement of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-mediated transmission, activation of intracellular signalling pathways and increase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aleksandrova, Lily R., Wang, Yu Tian, Phillips, Anthony G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292673/ https://www.ncbi.nlm.nih.gov/pubmed/30556028 http://dx.doi.org/10.1177/2470547017743511

Ejemplares similares

S-Ketamine oral thin film—Part 2: Population pharmacodynamics of S-ketamine, S-norketamine and S-hydroxynorketamine
por: Simons, Pieter, et al.
Publicado: (2022)

S-Ketamine Oral Thin Film—Part 1: Population Pharmacokinetics of S-Ketamine, S-Norketamine and S-Hydroxynorketamine
por: Simons, Pieter, et al.
Publicado: (2022)

Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors
por: Joseph, Thomas T., et al.
Publicado: (2021)

Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
por: Shirayama, Yukihiko, et al.
Publicado: (2017)

The distribution and clearance of (2S,6S)-hydroxynorketamine, an active ketamine metabolite, in Wistar rats
por: Moaddel, Ruin, et al.
Publicado: (2015)

Is the History Repeated? Can (2R,6R)-Hydroxynorketamine be Another Antidepressant?
por: Chaki, Shigeyuki, et al.
Publicado: (2018)

Ketamine may block NMDA receptors in astrocytes causing a rapid antidepressant effect
por: Mitterauer, Bernhard J.
Publicado: (2012)

Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
por: Wei, Yan, et al.
Publicado: (2021)

GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine
por: Miller, Oliver H, et al.
Publicado: (2014)

(R,S)-ketamine and (2R,6R)-hydroxynorketamine differentially affect memory as a function of dosing frequency
por: Riggs, Lace M., et al.
Publicado: (2021)

(2S,6S)- and (2R,6R)-hydroxynorketamine inhibit the induction of NMDA receptor-dependent LTP at hippocampal CA1 synapses in mice
por: Kang, Heather, et al.
Publicado: (2020)

Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression
por: Aleksandrova, Lily R., et al.
Publicado: (2020)

Longitudinal CSF proteome profiling in mice to uncover the acute and sustained mechanisms of action of rapid acting antidepressant (2R,6R)-hydroxynorketamine (HNK)
por: Herzog, David P., et al.
Publicado: (2021)

Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine
por: Tarrés-Gatius, Mireia, et al.
Publicado: (2020)

Ketamine Alters Functional Plasticity of Astroglia: An Implication for Antidepressant Effect
por: Stenovec, Matjaž
Publicado: (2021)

Role of Serotonergic System in the Antidepressant Actions of mGlu2/3 Receptor Antagonists: Similarity to Ketamine
por: Chaki, Shigeyuki, et al.
Publicado: (2019)

Antinociceptive and Analgesic Effects of (2R,6R)-Hydroxynorketamine
por: Yost, Jonathan G., et al.
Publicado: (2022)

NMDAR inhibition-independent antidepressant actions of ketamine metabolites
por: Zanos, Panos, et al.
Publicado: (2016)

Immunoregulation and antidepressant effect of ketamine
por: Zhang, Nan, et al.
Publicado: (2021)

Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice
por: Tang, Juanjuan, et al.
Publicado: (2015)

Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
por: Zeiler, F. A.
Publicado: (2015)

Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation
por: Mitchell, Jules S., et al.
Publicado: (2023)

The Ketamine Antidepressant Story: New Insights
por: Alshammari, Tahani K.
Publicado: (2020)

Opioid Properties of Nitrous Oxide and Ketamine Contribute to Their Antidepressant Actions
por: Gillman, Mark A
Publicado: (2021)

Opposite Modulation of the NMDA Receptor by Glycine and S-Ketamine and the Effects on Resting State EEG Gamma Activity: New Insights into the Glutamate Hypothesis of Schizophrenia
por: Haaf, Moritz, et al.
Publicado: (2023)

Ketamine Decreases Resting State Functional Network Connectivity in Healthy Subjects: Implications for Antidepressant Drug Action
por: Scheidegger, Milan, et al.
Publicado: (2012)

A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice
por: Zanos, Panos, et al.
Publicado: (2017)

Mechanisms of Sustained Increases in γ Power Post-Ketamine in a Computational Model of the Hippocampal CA3: Implications for Ketamine’s Antidepressant Mechanism of Action
por: Petzi, Maximilian, et al.
Publicado: (2023)

Knockdown of BNST GluN2B-containing NMDA receptors mimics the actions of ketamine on novelty-induced hypophagia
por: Louderback, K M, et al.
Publicado: (2013)

Non-NMDA Mechanisms of Analgesia in Ketamine Analogs
por: Voss, Logan J., et al.
Publicado: (2022)

Effects of Monoamines and Antidepressants on Astrocyte Physiology: Implications for Monoamine Hypothesis of Depression
por: Marathe, Swananda V, et al.
Publicado: (2018)

Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
por: Matveychuk, Dmitriy, et al.
Publicado: (2020)

Activation of σ1-Receptors by R-Ketamine May Enhance the Antidepressant Effect of S-Ketamine
por: Kalkman, Hans O.
Publicado: (2023)

Sexually Dimorphic Behavioral Profile in a Transgenic Model Enabling Targeted Recombination in Active Neurons in Response to Ketamine and (2R,6R)-Hydroxynorketamine Administration
por: Herzog, David P., et al.
Publicado: (2020)

NMDA Receptor Antagonist Ketamine Impairs Feature Integration in Visual Perception
por: Meuwese, Julia D. I., et al.
Publicado: (2013)

Ketamine: stimulating antidepressant treatment?
por: Malhi, Gin S., et al.
Publicado: (2016)

Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action
por: Ficek, Joanna, et al.
Publicado: (2016)

No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation Model
por: Chang, Lijia, et al.
Publicado: (2018)

Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression
por: Lullau, August P. M., et al.
Publicado: (2023)

NMDA Receptor Glycine Binding Site Modulators for Prevention and Treatment of Ketamine Use Disorder
por: Hsiao, Yu-Chin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6v8ud1le9bc0o6qbvign3ilpjg